“Treat-to-Target Outcomes and Measures of Treatment Success in Three Phase 3 Trials of Tapinarof Cream 1% Once Daily for Mild to Severe Plaque Psoriasis”. SKIN The Journal of Cutaneous Medicine, vol. 6, no. 6, Nov. 2022, p. s52, https://doi.org/10.25251/skin.6.supp.52.